CorMedix (CRMD) Other Non-Current Assets (2010 - 2025)
CorMedix's (CRMD) quarterly Other Non-Current Assets came in at $642066.0 in Q2 2025, up 514.85% year-on-year from $104426.0 in Q2 2024, and little changed quarter-over-quarter from $642066.0 in Q1 2025.
CorMedix (CRMD) Other Non-Current Assets (2010 - 2025) Analysis & Trends
CorMedix has disclosed Other Non-Current Assets across 15 years of filings, most recently posting $642066.0 for Q2 2025.
- Other Non-Current Assets for Q2 2025 came in at $642066.0, up 514.85% year-over-year; the trailing twelve-month figure through Jun 2025 was $642066.0 (up 514.85% YoY), and the FY2024 annual result was $105368.0, up 36.84% from the prior year.
- Other Non-Current Assets came in at $642066.0 for Q2 2025 at CorMedix, roughly flat from $642066.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $642066.0 in Q1 2025 to a low of $77000.0 in Q4 2023.
- The 5-year median for Other Non-Current Assets is $103251.0 (2023), against an average of $164763.2.
- Across the five-year window, Other Non-Current Assets plunged 79.57% in 2021 and soared 518.33% in 2025, its largest moves.
- CorMedix's Other Non-Current Assets stood at $102305.0 in 2021, then climbed by 21.21% to $124000.0 in 2022, then plunged by 37.9% to $77000.0 in 2023, then jumped by 36.84% to $105368.0 in 2024, then soared by 509.36% to $642066.0 in 2025.
- The last three Other Non-Current Assets figures came in at $642066.0 (Q2 2025), $642066.0 (Q1 2025), and $105368.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 642,066.00 |
| Mar 31, 2025 | 642,066.00 |
| Dec 31, 2024 | 105,368.00 |
| Sep 30, 2024 | 105,084.00 |
| Jun 30, 2024 | 104,426.00 |
| Mar 31, 2024 | 103,838.00 |
| Dec 31, 2023 | 77,000.00 |
| Sep 30, 2023 | 102,664.00 |
| Jun 30, 2023 | 102,370.00 |
| Mar 31, 2023 | 102,345.00 |
| Dec 31, 2022 | 124,000.00 |
| Sep 30, 2022 | 114,000.00 |
| Jun 30, 2022 | 102,308.00 |
| Mar 31, 2022 | 129,000.00 |
| Dec 31, 2021 | 102,305.00 |
| Sep 30, 2021 | 102,302.00 |
| Jun 30, 2021 | 102,300.00 |
| Mar 31, 2021 | 102,295.00 |
| Dec 31, 2020 | 191,000.00 |
| Sep 30, 2020 | 182,892.00 |